Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-13

FDA Approved: NEVIRAPINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for Nevirapine from Aurobindo Pharma Limited. This action updates the approval of Nevirapine, a drug used to treat H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)

Snippet

SUPPL AP for NEVIRAPINE (NEVIRAPINE)